IRIS
MIELE, GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 173
EU - Europa 153
AS - Asia 11
AF - Africa 3
Totale 340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 173
IE - Irlanda 100
IT - Italia 24
DE - Germania 12
CN - Cina 6
FI - Finlandia 5
GB - Regno Unito 5
IN - India 5
BE - Belgio 4
MA - Marocco 3
SE - Svezia 2
LU - Lussemburgo 1
Totale 340
Salva come PNG Salva come JPEG
Città #
Dublin 100
Chandler 33
New York 22
Cambridge 13
Naples 8
Roxbury 8
Princeton 7
Pasadena 6
Beijing 5
Bremen 4
Brussels 4
Milan 4
Munich 4
Helsinki 3
Meknes 3
Norwich 3
Pune 3
Rockville 3
Ann Arbor 2
Ashburn 2
Boardman 2
Hyderabad 2
Lappeenranta 2
Atlanta 1
Battipaglia 1
Grafing 1
Luxembourg 1
L’Aquila 1
Napoli 1
New Haven 1
Norwalk 1
Putignano 1
Sala Consilina 1
Sulmona 1
Woodbridge 1
Totale 255
Salva come PNG Salva come JPEG
Nome #
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 49
Telemedicine application to headache: a critical review 43
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 33
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 28
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 25
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 24
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 24
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 20
Expectations for the high-energy neutrino detection from starburst galaxies with KM3NeT/ARCA 19
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 18
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 18
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 11
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 8
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 8
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 8
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 7
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 7
Pain, quality of life, and religiosity in people with multiple sclerosis 6
Validation of the swallowing disturbance questionnaire in people with multiple sclerosis 2
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 1
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 1
Totale 360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202253 0 0 3 1 4 4 0 1 1 0 13 26
2022/2023174 27 7 2 3 9 9 1 7 89 4 7 9
2023/2024133 10 12 13 14 34 32 11 1 5 1 0 0
Totale 360